Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
$199 (per month for a 12-month plan paid in full) Key Benefits A Compounded Semaglutide (GLP-1) injection designed to help manage appetite and support sustainable weight care while addressing underlying metabolic health factors for long-term results
Novo Nordisk said it is not currently conducting any clinical studies to evaluate semaglutide in patients with substance-use disorders or addiction-related illnesses, although changes in alcohol consumption is a secondary goal of a trial it is conducting of semaglutide in combination with other medicines in patients with alcohol-related liver disease
When in doubt, convert everything to the same unit before calculating
Semin Liver Dis (2007) 27(4):41326.10.1055/s-2007-991517 148 BatallerRBrennerDA
US$ 22.46
US$ 21.45
US$ 20.00
